Giant Cell Tumor of Tendon Sheath

Giant cell tumour of the tendon sheath (GCTTS) is a benign neoplastic condition that predominantly affects the synovial lining of tendons. As the second most prevalent tumor of the hand, it often poses diagnostic and therapeutic challenges to healthcare professionals. Understanding the pathology, diagnosis, treatment, and potential for recurrence is crucial for effective management of this condition.

---

Understanding Tenosynovial Giant Cell Tumor

The term "tenosynovial giant cell tumor" encompasses two main variants: localized (also known as giant cell tumour of the tendon sheath) and diffuse (pigmented villonodular synovitis). These tumours are characterized histologically by multinucleated giant cells, mononuclear histiocyte-like cells, and hemosiderin deposits.

Pathology Outlines

The pathology of giant cell tumors of the tendon sheath is well-documented. These tumours typically present as firm, well-circumscribed nodules. Histologically, they are comprised of a mixture of mononuclear cells, osteoclast-like giant cells, foam cells, and hemosiderin-laden macrophages. The presence of hemosiderin gives the tumour its characteristic brownish appearance.

While benign, GCTTS can be locally aggressive, leading to joint destruction and functional impairment if left untreated. This underscores the importance of early detection and appropriate management.

---

Clinical Presentation and Symptoms

GCTTS primarily affects adults, with a slight female predominance. Patients typically present with a slow-growing, painless mass near a joint or tendon, most commonly in the fingers or hands. On occasion, patients may experience pain or discomfort, particularly if the tumour compresses adjacent structures.

GCTTS Symptoms

---

Diagnostic Approach to GCTTS

The diagnosis of GCTTS is multi-faceted, involving clinical evaluation, imaging, and histopathological examination.

Radiology

Radiographic imaging plays a pivotal role in the assessment of GCTTS. X-rays may reveal soft tissue swelling, while MRI is superior for delineating the extent of the tumour and its relation to adjacent structures. On MRI, GCTTS typically appears as a well-defined mass with low to intermediate signal intensity on T1-weighted images and variable intensity on T2-weighted images due to hemosiderin content.

Histopathological Examination

Definitive diagnosis is achieved through histopathological analysis. The biopsy will reveal the characteristic multinucleated giant cells and mononuclear histiocyte-like cells. Immunohistochemical staining may assist in differentiating GCTTS from other soft tissue tumours.

---

Treatment Modalities for Giant Cell Tumor of Tendon Sheath

The primary treatment for GCTTS is surgical excision. The goal of surgery is the complete removal of the tumour to minimize the risk of recurrence.

GCTTS Surgery

Surgical excision involves careful dissection to preserve surrounding structures while ensuring complete removal of the tumor. Incomplete excision is the main risk factor for recurrence, making meticulous surgical technique essential.

Postoperative Care

Post-surgery, patients may require physical therapy to restore function and prevent stiffness, especially if the tumour is located near a joint. Pain management and monitoring for signs of recurrence are also integral components of postoperative care.

Non-Surgical Treatment

In cases where surgery is contraindicated or the patient is at high risk for complications, alternative treatments such as radiation therapy or targeted therapies may be considered. However, these are less commonly employed and are typically reserved for cases where surgical intervention is not feasible.

---

Recurrence and Long-term Outlook

Recurrence is a well-recognized complication of GCTTS, with rates varying between 10% and 20% following surgical excision. Factors contributing to recurrence include incomplete resection and the anatomical location of the tumour.

Monitoring for Recurrence

Regular follow-up is essential to detect recurrence early. Clinical examination and imaging may be utilized to monitor for signs of tumour regrowth. In the event of recurrence, repeat surgical intervention is often required.

Prognosis

Despite the potential for recurrence, the prognosis for patients with GCTTS is generally favourable. With appropriate treatment, most patients achieve good functional outcomes. However, ongoing monitoring is crucial to address any complications promptly.